# Aisling Capital LLC

> Institutional holdings reported to the SEC as of Q3 2019 on Form 13F. CIK 1571076. Source: https://holderbook.com/funds/1571076-aisling-capital-llc/

- Reported value: $45.3M
- Positions: 4
- Weight of the ten largest: 100.0%
- Filed: 2019-11-13

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| AIMMUNE THERAPEUTICS INC | [AIMT](https://holderbook.com/stocks/AIMT/) | $26.0M | 1,240,000 | 57.3% | 4 |
| ADMA BIOLOGICS INC | [ADMA](https://holderbook.com/stocks/ADMA/) | $16.1M | 3,608,171 | 35.5% | 4 |
| CIDARA THERAPEUTICS INC COM NEW | [CDTXXXXX](https://holderbook.com/stocks/CDTXXXXX/) | $1.8M | 891,614 | 3.9% | 4 |
| TRANSENTERIX INC | [TRXC](https://holderbook.com/stocks/TRXC/) | $1.5M | 2,389,352 | 3.3% | 4 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2019 | $45.3M | 4 |
| Q2 2019 | $60.3M | 4 |
| Q1 2019 | $66.5M | 4 |
| Q4 2018 | $353.1M | 9 |